Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
clinical trials
fda
7
×
life sciences
national blog main
national top stories
boston blog main
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
amgen
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
drugs
genentech
investing
merck
migraine
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
4d molecular therapeutics
acne
What
approved
7
×
fda
drug
medicines
new
therapeutics
treat
approval
class
developed
friday
late
migraine
nod
oral
pill
therapy
treatment
wins
won
adults
affects
agency
aimmune
allergan
allergy
americans
announced
atrophy
awarded
bio
cholesterol
combo
companies
daily
date
decision
developing
digital
disease
Language
unset
Current search:
approved
×
biotech
×
fda
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines